Navigation Links
Global Cardiovascular Drug Delivery Technologies, Markets and Companies Report 2016-2025 - Research and Markets
Date:4/8/2016

DUBLIN, April 8, 2016 /PRNewswire/ --

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Cardiovascular Drug Delivery - Technologies, Markets and Companies" to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

The cardiovascular drug delivery markets are estimated for the years 2015 to 2025 on the basis of epidemiology and total markets for cardiovascular therapeutics. The estimates take into consideration the anticipated advances and availability of various technologies, particularly drug delivery devices in the future. Markets for drug-eluting stents are calculated separately. Role of drug delivery in developing cardiovascular markets is defined and unmet needs in cardiovascular drug delivery technologies are identified. 

Cell-selective targeted drug delivery has emerged as one of the most significant areas of biomedical engineering research, to optimize the therapeutic efficacy of a drug by strictly localizing its pharmacological activity to a pathophysiologically relevant tissue system. These concepts have been applied to targeted drug delivery to the cardiovascular system. Devices for drug delivery to the cardiovascular system are also described. 

Role of drug delivery in various cardiovascular disorders such as myocardial ischemia, hypertension and hypercholesterolemia is discussed. Cardioprotection is also discussed. Some of the preparations and technologies are also applicable to peripheral arterial diseases. Controlled release systems are based on chronopharmacology, which deals with the effects of circadian biological rhythms on drug actions.A full chapter is devoted to drug-eluting stents as treatment for restenosis following stenting of coronary arteries.Fifteen companies are involved in drug-eluting stents. 

New cell-based therapeutic strategies are being developed in response to the shortcomings of available treatments for heart disease. Potential repair by cell grafting or mobilizing endogenous cells holds particular attraction in heart disease, where the meager capacity for cardiomyocyte proliferation likely contributes to the irreversibility of heart failure. Cell therapy approaches include attempts to reinitiate cardiomyocyte proliferation in the adult, conversion of fibroblasts to contractile myocytes, conversion of bone marrow stem cells into cardiomyocytes, and transplantation of myocytes or other cells into injured myocardium. 

Advances in molecular pathophysiology of cardiovascular diseases have brought gene therapy within the realm of possibility as a novel approach to treatment of these diseases. It is hoped that gene therapy will be less expensive and affordable because the techniques involved are simpler than those involved in cardiac bypass surgery, heart transplantation and stent implantation. Gene therapy would be a more physiologic approach to deliver vasoprotective molecules to the site of vascular lesion. Gene therapy is not only a sophisticated method of drug delivery; it may at time need drug delivery devices such as catheters for transfer of genes to various parts of the cardiovascular system.

Selected 82 companies that either develop technologies for drug delivery to the cardiovascular system or products using these technologies are profiled and 80 collaborations between companies are tabulated. The bibliography includes 200 selected references from recent literature on this topic. The report is supplemented with 30 tables and 8 figures. 

Key Topics Covered: 

0. Executive Summary

1. Cardiovascular Diseases

2. Methods for Drug Delivery to the Cardiovascular System

3. Cell Therapy for Cardiovascular Disorders

4. Gene Therapy for Cardiovascular Disorders

5. Drug-Eluting Stents

6. Markets for Cardiovascular Drug Delivery

7. Companies involved in Cardiovascular Drug Delivery

8. References 

For more information visit http://www.researchandmarkets.com/research/nrtdc8/cardiovascular 

Source: Jain PharmaBiotech


Media Contact: 
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com


For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900    


U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


'/>"/>
SOURCE Research and Markets
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Laboratory and Handheld Raman Instruments Market 2016-2020 - Increased Spending on R&D -- Research and Markets
2. Global Dental Consumables Market is Expected to Expand at a CAGR of 5.7% From 2015 to 2023: Transparency Market Research
3. Global Non-Hematological Cancers Market to Hit $140.8 Billion by 2021, says GBI Research
4. Global Alzheimer Disease Report 2016 - New Drugs, Markets and Companies to 2025 Featuring 300+ Different Compounds at Various Stages of Development - Research and Markets
5. Global Nitric Oxide Therapeutics, Markets and Companies Study 2016 with Projections to 2020 & 2025 - Research and Markets
6. Global Animal Biotechnology Technologies, Markets and Companies Report 2016 - Research Activities of 11 Veterinary and Livestock Research Institutes With 108 Collaborations - Research and Markets
7. Global Gene Therapy Technologies, Markets and Companies Report 2016 - Analysis & Forecasts 2015-2025 - Research and Markets
8. Global Medication Adherence Market Expected to Grow With 17.5% CAGR During 2016-2022: P&S Market Research
9. Global Ultrasound Market Growth Steady at 5.5% CAGR to 2020
10. Global Age-Related Macular Degeneration Market Expected to Grow at 7.6% CAGR During 2016-2022: P&S Market Research
11. Global HCV Market: Gilead Sciences, AbbVie, J&J and Bristol-Myers Squibb Featured in 2016 Hepatitis C Virus Edition Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... , ... June 19, 2019 , ... ... exclusively for the promotion of social welfare and protection of physicians’ rights, asserts ... than the previous revision and still rely on narrow guidelines as a basis ...
(Date:6/19/2019)... ... June 19, 2019 , ... Center for Vein Restoration (CVR) CEO and Founder, ... CEOs in 2019 . Glassdoor , one of the world’s largest job ... leaders that employees love working for throughout North America and parts of Europe. Dr. ...
(Date:6/19/2019)... Pa. (PRWEB) , ... June 19, 2019 , ... ... nuclear receptor and in vitro toxicology testing solutions, announced the addition of the ... kit expands INDIGO’s existing in vitro toxicology offerings and allows researchers to perform ...
Breaking Medicine Technology:
(Date:6/25/2019)... DETROIT (PRWEB) , ... June 25, 2019 , ... Women’s ... and raised in Louisiana and has been a practicing midwife for over 3 years. ... years. April received her Master’s in Nursing from Frontier University and her undergraduate from ...
(Date:6/25/2019)... ... June 25, 2019 , ... Smile Brands Inc., one of ... than 400 affiliated offices across 17 states, is pleased to announce its latest ... will provide full-service administrative support to the practice, which includes purchasing, payroll, accounting, ...
(Date:6/25/2019)... ... June 25, 2019 , ... The Global Smile Foundation will ... July thanks to 15-year-old Kylie Azizzadeh’s efforts fundraising for the mission. She has already ... before the mission takes place on July 15, 2019. , In 2018, Kylie ...
(Date:6/24/2019)... ... 2019 , ... innovaTel Telepsychiatry, a leading provider of psychiatric ... Advisory Board (SAB) to help inform the Company’s efforts to bring telepsychiatry services ... , We are honored to announce that Linda Rosenberg, immediate past President and ...
(Date:6/24/2019)... (PRWEB) , ... June 24, 2019 , ... Exercising on ... cardio, people often try to mitigate this by running on softer surfaces, such as ... made of a rubber composite. Why not be able to have shock-absorption benefits ...
Breaking Medicine News(10 mins):